Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · IEX Real-Time Price · USD
2.140
+0.070 (3.38%)
At close: Apr 18, 2024, 4:00 PM
2.060
-0.080 (-3.74%)
After-hours: Apr 18, 2024, 7:59 PM EDT

Alterity Therapeutics Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Year 2023202220212020201920182017201620152014 2013 - 2000
Revenue
00000000.140.180.36
Upgrade
Revenue Growth (YoY)
--------19.33%-51.39%141.12%
Upgrade
Gross Profit
00000000.140.180.36
Upgrade
Selling, General & Admin
5.065.516.943.454.314.343.973.614.514.93
Upgrade
Research & Development
13.4815.1112.6410.4513.316.925.949.8312.5615.39
Upgrade
Other Operating Expenses
0.03000.040.130.060.130.050.040.45
Upgrade
Operating Expenses
18.5720.6319.5813.9417.7511.3210.0413.4817.120.76
Upgrade
Operating Income
-18.57-20.63-19.58-13.94-17.75-11.32-10.04-13.34-16.92-20.4
Upgrade
Interest Expense / Income
0000000000.03
Upgrade
Other Expense / Income
-4.87-7.85-4.27-0.48-5.41-3.06-2.49-5.61-11.04-7.1
Upgrade
Pretax Income
-13.7-12.78-15.31-13.46-12.34-8.27-7.54-7.73-5.89-13.33
Upgrade
Income Tax
0.10.0700000000
Upgrade
Net Income
-13.81-12.85-15.31-13.46-12.34-8.27-7.54-7.73-5.89-13.33
Upgrade
Shares Outstanding (Basic)
2,4282,4061,697895616534534534503428
Upgrade
Shares Outstanding (Diluted)
2,4282,4061,697895616534534534503428
Upgrade
Shares Change
0.91%41.79%89.62%45.33%15.34%--6.20%17.44%26.38%
Upgrade
EPS (Basic)
-3.42-3.18-5.40-9.00-12.00-9.30-8.46-8.70-7.02-18.66
Upgrade
EPS (Diluted)
-3.42-3.18-5.40-9.00-12.00-9.30-8.46-8.70-7.02-18.66
Upgrade
Free Cash Flow
-20.04-12.43-17.34-9.45-13.96-6.31-5.89-7.42-10.9-13.56
Upgrade
Free Cash Flow Per Share
-4.95-3.10-6.13-6.33-13.60-7.09-6.62-8.34-13.01-19.00
Upgrade
Gross Margin
-------100.00%100.00%100.00%
Upgrade
Operating Margin
--------9351.45%-9570.10%-5607.33%
Upgrade
Profit Margin
--------5418.28%-3327.87%-3664.14%
Upgrade
Free Cash Flow Margin
--------5201.87%-6163.60%-3727.38%
Upgrade
EBITDA
--12.78-15.31-13.46-12.34-8.27-7.54-7.73-5.89-13.3
Upgrade
EBITDA Margin
--------5418.28%-3327.87%-3655.90%
Upgrade
EBIT
-13.7-12.78-15.31-13.46-12.34-8.27-7.54-7.73-5.89-13.3
Upgrade
EBIT Margin
--------5418.28%-3327.87%-3655.90%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).